Chronic Kidney Disease

Empagliflozin Receives FDA Fast Track Designation for Treatment of Kidney Disease
March 12, 2020

FDA Fast Track designation is to investigate whether the diabetes medication can also reduce kidney disease progression.

Heart Failure, Other CVD Increase Risk for ESRD
January 10, 2020

Cardiovascular diseases, particularly heart failure, were found significantly and independently associated with end-stage renal disease in a new analysis.

Risk-Based Kidney Care May Be On the Way
December 11, 2019

New risk prediction models may help identify patients with and without diabetes at elevated risk for chronic kidney disease, say authors of a recent study.